332 related articles for article (PubMed ID: 26863209)
21. 5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation.
Hutcheson JD; Ryzhova LM; Setola V; Merryman WD
J Mol Cell Cardiol; 2012 Nov; 53(5):707-14. PubMed ID: 22940605
[TBL] [Abstract][Full Text] [Related]
22. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
[TBL] [Abstract][Full Text] [Related]
23. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
[TBL] [Abstract][Full Text] [Related]
24. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
25. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
[TBL] [Abstract][Full Text] [Related]
26. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
27. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
[TBL] [Abstract][Full Text] [Related]
28. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension.
Han C; Hong KH; Kim YH; Kim MJ; Song C; Kim MJ; Kim SJ; Raizada MK; Oh SP
Hypertension; 2013 May; 61(5):1044-52. PubMed ID: 23478097
[TBL] [Abstract][Full Text] [Related]
29. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.
Song Y; Coleman L; Shi J; Beppu H; Sato K; Walsh K; Loscalzo J; Zhang YY
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H677-90. PubMed ID: 18552156
[TBL] [Abstract][Full Text] [Related]
30. BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.
Talati M; West J; Blackwell TR; Loyd JE; Meyrick B
Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L363-73. PubMed ID: 20562228
[TBL] [Abstract][Full Text] [Related]
31. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
32. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
[TBL] [Abstract][Full Text] [Related]
33. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.
Ogo T; Chowdhury HM; Yang J; Long L; Li X; Torres Cleuren YN; Morrell NW; Schermuly RT; Trembath RC; Nasim MT
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):733-41. PubMed ID: 23418342
[TBL] [Abstract][Full Text] [Related]
35. Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension.
Sawada H; Saito T; Nickel NP; Alastalo TP; Glotzbach JP; Chan R; Haghighat L; Fuchs G; Januszyk M; Cao A; Lai YJ; Perez Vde J; Kim YM; Wang L; Chen PI; Spiekerkoetter E; Mitani Y; Gurtner GC; Sarnow P; Rabinovitch M
J Exp Med; 2014 Feb; 211(2):263-80. PubMed ID: 24446489
[TBL] [Abstract][Full Text] [Related]
36. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling.
Zhang Y; Peng B; Han Y
Biomed Pharmacother; 2018 Jul; 103():1279-1286. PubMed ID: 29864909
[TBL] [Abstract][Full Text] [Related]
37. Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension.
Yu J; Taylor L; Wilson J; Comhair S; Erzurum S; Polgar P
J Cell Physiol; 2013 Feb; 228(2):322-9. PubMed ID: 22688668
[TBL] [Abstract][Full Text] [Related]
38. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
39. Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.
Chen X; Talati M; Fessel JP; Hemnes AR; Gladson S; French J; Shay S; Trammell A; Phillips JA; Hamid R; Cogan JD; Dawson EP; Womble KE; Hedges LK; Martinez EG; Wheeler LA; Loyd JE; Majka SJ; West J; Austin ED
Circulation; 2016 Jan; 133(1):82-97. PubMed ID: 26487756
[TBL] [Abstract][Full Text] [Related]
40. From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension.
Paulin R; Courboulin A; Barrier M; Bonnet S
J Mol Med (Berl); 2011 Nov; 89(11):1089-101. PubMed ID: 21761156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
